{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:20:44Z","timestamp":1793172044792,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007867","name":"Universit\u00e9 Laval","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007867","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015751","name":"Qu\u00e9bec Consortium for Drug Discovery","doi-asserted-by":"publisher","award":["Couture-QL-274"],"award-info":[{"award-number":["Couture-QL-274"]}],"id":[{"id":"10.13039\/100015751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015751","name":"Qu\u00e9bec Consortium for Drug Discovery","doi-asserted-by":"publisher","award":["511957-2018"],"award-info":[{"award-number":["511957-2018"]}],"id":[{"id":"10.13039\/100015751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.omtn.2024.102290","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T22:17:41Z","timestamp":1722377861000},"page":"102290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10"],"prefix":"10.1016","volume":"35","author":[{"given":"Maud","family":"Auger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Sorroza-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Brahiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole-Ann","family":"Hupp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Faucher-Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen","family":"Arbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Hervault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gaillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7839-173X","authenticated-orcid":false,"given":"Al-Halifa","family":"Soultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102290_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/tde-2017-0037","article-title":"Drug delivery to the lungs: challenges and opportunities","volume":"8","author":"Newman","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.omtn.2024.102290_bib2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/pharmaceutics12111025","article-title":"Pulmonary Delivery of Biological Drugs","volume":"12","author":"Liang","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtn.2024.102290_bib3","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2019.0160","article-title":"Multiscale mechanics of mucociliary clearance in the lung","volume":"375","author":"Nawroth","year":"2020","journal-title":"Philosophical Transactions of the Royal Society B"},{"key":"10.1016\/j.omtn.2024.102290_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.107502","article-title":"The approved gene therapy drugs worldwide: from 1998 to 2019","volume":"40","author":"Ma","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omtn.2024.102290_bib5","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcf.2021.12.012","article-title":"Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation","volume":"21","author":"Oren","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.omtn.2024.102290_bib7","article-title":"Exon-skipping antisense oligonucleotides for cystic fibrosis therapy","volume":"119","author":"Kim","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102290_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114886119","article-title":"Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis","volume":"119","author":"Michaels","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102290_bib9","author":"Ozeri-Galai"},{"key":"10.1016\/j.omtn.2024.102290_bib10","first-page":"271","article-title":"A review of antisense therapeutic interventions for molecular biological targets in asthma","volume":"1","author":"Popescu","year":"2007","journal-title":"Biologics."},{"key":"10.1016\/j.omtn.2024.102290_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114858","article-title":"Inhaled drug delivery for the targeted treatment of asthma","volume":"198","author":"Boboltz","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102290_bib12","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1038\/s41467-021-24598-4","article-title":"Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102290_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.coph.2005.07.001","article-title":"Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers","volume":"5","author":"Amantana","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.omtn.2024.102290_bib14","first-page":"235","article-title":"Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivation","volume":"3","author":"Iversen","year":"2001","journal-title":"Curr. Opin. Mol. Therapeut."},{"key":"10.1016\/j.omtn.2024.102290_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ymthe.2017.03.023","article-title":"FDA-Approved Oligonucleotide Therapies in 2017","volume":"25","author":"Stein","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102290_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.omtn.2024.102290_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4939-7374-3_9","article-title":"Exon skipping therapy using phosphorodiamidate morpholino oligomers in the mdx52 mouse model of duchenne muscular dystrophy","volume":"1687","author":"Miyatake","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102290_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1358\/dot.2020.56.8.3159186","article-title":"Golodirsen for Duchenne muscular dystrophy","volume":"56","author":"Anwar","year":"2020","journal-title":"Drugs Today"},{"key":"10.1016\/j.omtn.2024.102290_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2024.102290_bib20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biocel.2010.11.005","article-title":"Duchenne muscular dystrophy\u00a0\u2013 What causes the increased membrane permeability in skeletal muscle?","volume":"43","author":"Allen","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtn.2024.102290_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13395-018-0177-7","article-title":"Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers","volume":"8","author":"Houang","year":"2018","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.omtn.2024.102290_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/138920109789069279","article-title":"Cellular Uptake of Neutral Phosphorodiamidate Morpholino Oligomers","volume":"10","author":"Iversen","year":"2009","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.omtn.2024.102290_bib23","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1093\/nar\/gkab488","article-title":"Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung","volume":"49","author":"Dang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/biomedicines9050512","article-title":"Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery","volume":"9","author":"Juliano","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2024.102290_bib25","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.30","article-title":"Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment","volume":"1","author":"Betts","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102290_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02411-20","article-title":"Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa In\u00a0Vitro and In\u00a0Vivo","volume":"12","author":"Moustafa","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.omtn.2024.102290_bib28","first-page":"782","article-title":"Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in\u00a0vitro and in\u00a0vivo","volume":"72","author":"Sully","year":"2017","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.omtn.2024.102290_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.omtm.2020.03.011","article-title":"Combined\u00a0Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice","volume":"17","author":"Forand","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2024.102290_bib30","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/nar\/gkv060","article-title":"High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib31","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/nar\/gkx1320","article-title":"Structure\u2013activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides","volume":"46","author":"Juliano","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib32","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acschembio.7b00242","article-title":"A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides","volume":"12","author":"Wang","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2024.102290_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.omtn.2022.10.025","article-title":"Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy","volume":"30","author":"Gushchina","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2024.102290_bib34","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.bbamem.2010.02.012","article-title":"Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy","volume":"1798","author":"Moulton","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102290_bib35","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-019-12922-y","article-title":"Engineered amphiphilic peptides enable delivery of proteins and CRISPR-associated nucleases to airway epithelia","volume":"10","author":"Krishnamurthy","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102290_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/hum.2023.016","article-title":"Genome Editing in Ferret Airway Epithelia Mediated by CRISPR\/Nucleases Delivered with Amphiphilic Shuttle Peptides","volume":"34","author":"Luo","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2024.102290_bib37","first-page":"1","article-title":"Shuttle Peptide Delivers Base Editor RNPs to Rhesus Monkey Airway Epithelial","volume":"14","author":"Kulhankova","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.omtn.2024.102290_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12964-021-00741-y","article-title":"Types of nuclear localization signals and mechanisms of protein import into the nucleus","volume":"19","author":"Lu","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.omtn.2024.102290_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2011.01.030","article-title":"Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery","volume":"152","author":"Cheng","year":"2011","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtn.2024.102290_bib40","series-title":"Smart internal stimulus-responsive nanocarriers for drug and gene delivery","first-page":"1","author":"Karimi","year":"2015"},{"key":"10.1016\/j.omtn.2024.102290_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1139\/bcb-2018-0189","article-title":"Glutathione: subcellular distribution and membrane transport","volume":"97","author":"Oestreicher","year":"2019","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.omtn.2024.102290_bib42","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/molecules25102314","article-title":"Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals","volume":"25","author":"Evans","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omtn.2024.102290_bib43","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.3390\/ijms22168677","article-title":"Recent Applications of Retro-Inverso Peptides","volume":"22","author":"Doti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102290_bib44","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbagen.2008.01.011","article-title":"Redox compartmentalization in eukaryotic cells","volume":"1780","author":"Go","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtn.2024.102290_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201900531","article-title":"Disulfide-Based Self-Immolative Linkers and Functional Bioconjugates for Biological Applications","volume":"41","author":"Deng","year":"2020","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.omtn.2024.102290_bib46","first-page":"2914","article-title":"SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production","volume":"119","author":"Chen","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102290_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/ajrcmb.19.1.2930","article-title":"Induction, Duration, and Resolution of Airway Goblet Cell Hyperplasia in a Murine Model of Atopic Asthma: Effect of Concurrent Infection with Respiratory Syncytial Virus and Response to Dexamethasone","volume":"19","author":"Blyth","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102290_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.nmd.2015.08.005","article-title":"The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development","volume":"25","author":"Vulin","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtn.2024.102290_bib49","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1093\/nar\/29.19.3965","article-title":"Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs","volume":"29","author":"Sazani","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6020051","article-title":"Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics","volume":"6","author":"McClorey","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2024.102290_bib51","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1093\/nar\/gkm418","article-title":"Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide","volume":"35","author":"Abes","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102290_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.02.008","article-title":"Delivery of therapeutic oligonucleotides with cell penetrating peptides","volume":"87","author":"Boisgu\u00e9rin","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102290_bib53","series-title":"CPP, Cell-Penetrating Peptides","first-page":"345","article-title":"Toxicity and Immune Response","author":"Langel","year":"2023"},{"key":"10.1016\/j.omtn.2024.102290_bib54","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/mt.2008.81","article-title":"Inhibition of respiratory syncytial virus infections with morpholino oligomers in cell cultures and in mice","volume":"16","author":"Lai","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102290_bib55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jconrel.2006.09.011","article-title":"Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents","volume":"116","author":"Abes","year":"2006","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.omtn.2024.102290_bib56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1023\/A:1008850300184","article-title":"Structure\u2013activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein","volume":"4","author":"Viv\u00e8s","year":"1997","journal-title":"Lett. Pept. Sci."},{"key":"10.1016\/j.omtn.2024.102290_bib57","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.procbio.2016.09.029","article-title":"Effect of protein immunogenicity and PEG size and branching on the anti-PEG immune response to PEGylated proteins","volume":"52","author":"Wan","year":"2017","journal-title":"Process Biochem."},{"key":"10.1016\/j.omtn.2024.102290_bib58","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus","volume":"272","author":"Viv\u00e8s","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2024.102290_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: Immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtn.2024.102290_bib60","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.0014-2956.2001.02671.x","article-title":"Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins<\/br>fused to Tat","volume":"269","author":"Silhol","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtn.2024.102290_bib61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2020.258525","article-title":"Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia","volume":"107","author":"Khalil","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.omtn.2024.102290_bib62","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.omtn.2024.102290_bib63","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.stem.2019.12.014","article-title":"Distinct Airway Epithelial Stem Cells Hide among Club Cells but Mobilize to Promote Alveolar Regeneration","volume":"26","author":"Kathiriya","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2024.102290_bib64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature12777","article-title":"Dedifferentiation of committed epithelial cells into stem cells in\u00a0vivo","volume":"503","author":"Tata","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2024.102290_bib65","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.stem.2009.04.002","article-title":"The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, Epithelium","volume":"4","author":"Rawlins","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2024.102290_bib66","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/acs.biomac.3c00603","article-title":"PEGylation of a peptide-based amphiphilic delivery agent and influence on protein delivery to cells","volume":"24","author":"Greschner","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.omtn.2024.102290_bib67","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1073\/pnas.0906850106","article-title":"Basal cells as stem cells of the mouse trachea and human airway epithelium","volume":"106","author":"Rock","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102290_bib68","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1038\/s41467-022-32052-2","article-title":"Club cells employ regeneration mechanisms during lung tumorigenesis","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102290_bib69","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jcf.2022.03.007","article-title":"Club cell secretory protein and lung function in children with cystic fibrosis","volume":"21","author":"Zhai","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.omtn.2024.102290_bib70","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1038\/s41467-021-23277-8","article-title":"Club cell-specific role of programmed cell death 5 in pulmonary fibrosis","volume":"12","author":"Park","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2024.102290_bib71","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1183\/09031936.00134214","article-title":"Protective role for club cell secretory protein-16 (CC16) in the development of COPD","volume":"45","author":"Laucho-Contreras","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtn.2024.102290_bib72","doi-asserted-by":"crossref","first-page":"L652","DOI":"10.1152\/ajplung.00192.2022","article-title":"An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease","volume":"324","author":"Blackburn","year":"2023","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.omtn.2024.102290_bib73","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1016\/S2214-109X(23)00217-6","article-title":"The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020\u201350: a health-augmented macroeconomic modelling study","volume":"11","author":"Chen","year":"2023","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.omtn.2024.102290_bib75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/108729003768247583","article-title":"Effects of base modifications on antisense properties of 2\u2019-O-methoxyethyl and PNA oligonucleotides","volume":"13","author":"Sazani","year":"2003","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/j.omtn.2024.102290_bib76","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nbt759","article-title":"Systemically delivered antisense oligomers upregulate gene expression in mouse tissues","volume":"20","author":"Sazani","year":"2002","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312400177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312400177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:55:27Z","timestamp":1778838927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312400177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S216225312400177X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102290","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102290"}}